Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
OrganiGram Holdings Inc(OGI)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for OGI
09/25/2026: OGI (1-star) is currently NOT-A-BUY. Pass it for now.
OrganiGram Holdings Inc is a Canadian cannabis producer focused on indoor cultivation and the development of value-added products like edibles. The company is known for its high-quality standards and has bolstered its position through a strategic partnership with British American Tobacco. While this partnership provides essential capital, OrganiGram faces persistent risks, including intense price competition and a challenging regulatory environment in Canada. The company is best suited for speculative investors interested in the cannabis sector who can tolerate high volatility. Key developments to monitor include progress toward sustainable operating cash flow and the successful expansion of international export channels to mitigate domestic market saturation.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | The company offers potential for expansion but faces significant headwinds in the current cannabis sector. |
| Momentum investor | Weak fit | Stock performance is highly volatile and often lacks sustained upward momentum. |
| Value investor | Weak fit | Profitability remains inconsistent, making traditional value metrics difficult to apply. |
| Dividend investor | Weak fit | The company does not pay dividends and prioritizes capital preservation. |
| Low-risk investor | Weak fit | The cannabis industry entails high regulatory and market risks unsuitable for low-risk portfolios. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | The stock is susceptible to large price swings driven by sector sentiment. |
| Valuation risk | Medium / high | Market valuations in cannabis often decoupled from near-term fundamentals. |
| Competition risk | High | Saturation in the Canadian market forces margin-crushing price competition. |
| Business quality | Medium | The business model is evolving but still relies on navigating difficult regulatory environments. |
| Dividend income | Low / none | There is no dividend income for investors. |
| Execution risk | Medium / high | Achieving consistent profitability while scaling is a significant operational challenge. |
Price Behavior
Steep Decline
The stock price has dropped sharply with strong downward pressure.
Choppy
The stock has experienced frequent reversals and pronounced short-term price swings.
Analysis of Past Performance
Type Stock | Historic Profit -42.03% | Avg. Invested days 27 | Today’s Advisory PASS |
Upturn Advisory Rating  | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/25/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 158.57M USD | Price to earnings Ratio 2.56 | 1Y Target Price 8.8 |
Price to earnings Ratio 2.56 | 1Y Target Price 8.8 | ||
Volume (30-day avg) 542.5K shares | Beta 1.91 | 52 Weeks Range 0.85 - 2.24 | Updated Date 09/25/2026 |
52 Weeks Range 0.85 - 2.24 | Updated Date 09/25/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.43 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Recreational Cannabis | Dried flower, pre-rolls, and vaporizable products sold to provincial boards. | This is the primary revenue driver, dependent on consumer demand and provincial retail network performance. |
| Cannabis Derivatives | Gummies, chocolates, and other infused products. | These products typically carry higher margins and are key to brand differentiation. |
| International Exports | Sales of cannabis products to international medical markets. | This represents an optionality play for future growth outside of the saturated Canadian market. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Valuation
Trailing PE 2.56 | Forward PE 15.67 | Enterprise Value 175.37M | Price to Sales(TTM) 0.51 |
Enterprise Value 175.37M | Price to Sales(TTM) 0.51 | ||
Enterprise Value to Revenue 0.8 | Enterprise Value to EBITDA 13.37 | Shares Outstanding 144.15M | Shares Floating 97.33M |
Shares Outstanding 144.15M | Shares Floating 97.33M | ||
Percent Insiders 31.06 | Percent Institutions 6.54 |
Upturn AI Summary
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
About OrganiGram Holdings Inc
Exchange NASDAQ | Headquarters Toronto, ON, Canada | ||
IPO Launch date 2014-08-27 | CEO & Director Mr. James H. Yamanaka | ||
Sector Healthcare | Industry Drug Manufacturers - Specialty & Generic | Full time employees 1139 | Website https://www.organigram.ca |
Full time employees 1139 | Website https://www.organigram.ca | ||
Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates; and adult use recreational cannabis under the SHRED, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Edison JOLTS, Wola, Rizzlers, DEBUNK, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings and dried flowers to other licensed producers. It sells cannabis products to wholesale and retail channels in the recreational and medical cannabis regimes, as well as through online. Organigram Global Inc. was formerly known as Organigram Holdings Inc. and changed its name to Organigram Global Inc. in March 2025. The company is headquartered in Toronto, Canada.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.